JP Morgan Chase’s Precigen PGEN Stock Holding History

JP Morgan Chase’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,400	Closed	-$27K	–	6906
2021 Q4	$27K	Hold	7,400	–	–	﹤0.01%	6136
2021 Q3	$37K	Hold	7,400	–	–	﹤0.01%	5913
2021 Q2	$48K	Hold	7,400	–	–	﹤0.01%	5744
2021 Q1	$51K	Buy	+7,400	New	+$62.6K	﹤0.01%	5528
2020 Q4	–	Sell	-3,000	Closed	-$11K	–	5857
2020 Q3	$11K	Buy	3,000 +2,000	+200%	+$9.49K	﹤0.01%	5246
2020 Q2	$5K	Buy	+1,000	New	+$3.4K	﹤0.01%	5188
2020 Q1	–	Sell	-10,000	Closed	-$55K	–	5622
2019 Q4	$55K	Hold	10,000	–	–	﹤0.01%	5096
2019 Q3	$57K	Sell	10,000 -450,000	-98%	-$3.06M	﹤0.01%	5124
2019 Q2	$3.51M	Buy	+460,000	New	+$2.48M	﹤0.01%	2928
2019 Q1	–	Sell	-62,400	Closed	-$408K	–	5966
2018 Q4	$408K	Hold	62,400	–	–	﹤0.01%	4236
2018 Q3	$1.07M	Sell	62,400 -13,800	-18%	-$205K	﹤0.01%	3872
2018 Q2	$1.06M	Hold	76,200	–	–	﹤0.01%	3802
2018 Q1	$1.17M	Buy	+76,200	New	+$1.09M	﹤0.01%	3584

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase's PGEN Position: Q2 2026 in Review

JP Morgan Chase reduced its Precigen (PGEN) stake by 2.7% in Q2 2026, selling an estimated $104K and leaving 849,298 shares worth $5.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3441.

JP Morgan Chase first reported a position in PGEN in Q3 2013 and has held it in 52 quarters since. The position peaked at $16.6M in Q1 2015. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

JP Morgan Chase held 849,298 shares of Precigen worth $5.08M as of Q2 2026.
JP Morgan Chase sold 23,985 Precigen shares in Q2 2026, an estimated $104K.
Precigen made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3441 holding.
JP Morgan Chase first reported a position in Precigen in Q3 2013 and has held it in 52 quarters since.
JP Morgan Chase's Precigen position peaked at $16.6M in Q1 2015.
211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.